Jasmin Walter
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jasmin Walter has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Ulrich Bleul
Department of Farm Animals, Clinic of Reproductive Medicine, Vetsuisse Faculty, University of Zurich, 8057 Zurich, Switzerland
6 shared publications B. Roschitzki
Functional Genomics Centre Zurich, University and ETH Zurich, Zurich, Switzerland
3 shared publicationsC. Fortes
Functional Genomics Centre Zurich, University and ETH Zurich, Zurich, Switzerland
3 shared publicationsJ. Grossmann
Functional Genomics Centre Zurich, University and ETH Zurich, Zurich, Switzerland
3 shared publications- Nikolaus Osterrieder
Institut für Virologie, Freie Universität Berlin, 14163 Berlin, Germany
3 shared publications A. Wehrend
2 shared publications
Latest Publications
- Open Access
- 12 September 2024
- Published by Oxford University Press (OUP) in Molecular Human Reproduction
- Vol. 30 (9)
Maturational competence of equine oocytes is associated with alterations in their ‘cumulome’
Assisted reproductive technologies are an emerging field in equine reproduction, with species dependent peculiarities, such as the low success rate of conventional in vitro fertilisation. Here, the “cumulome” was related to the developmental capacity of its corresponding oocyte. Cumulus oocyte complexes (COCs) collected from slaughterhouse ovaries were individually matured, fertilised by intracytoplasmic sperm injection (ICSI), and cultured. After maturation, the cumulus was collected for proteomics analysis using label-free mass spectrometry (MS) based protein profiling by nano-HPLC MS/MS and metabolomics analysis by UPLC-nanoESI MS. Overall, a total of 1671 proteins and 612 metabolites were included in the quantifiable “cumulome”. According to the development of the corresponding oocytes, three groups were compared with each other: not matured (NM; n = 18), cleaved (CV; n = 15) and blastocyst (BL; n = 19) groups. CV and BL were also analysed together as the matured group (M; n = 34). The dataset revealed a closer connection within the two M groups and a more distinct separation from the NM group. Over-representation analysis detected enrichments related to energy metabolism as well as vesicular transport in the M group. Functional enrichment analysis found only the KEGG pathway of oxidative phosphorylation as significantly enriched in NM group. A compound attributed to ATP was observed with significantly higher concentrations in the BL group compared with the NM group. Finally, in the NM group, proteins related to degradation of glycosaminoglycans were lower and components of cumulus extracellular matrix were higher compared to the other groups. In summary, the study revealed novel pathways associated with the maturational and developmental competence of oocytes.
- 12 September 2024
- Published by Oxford University Press (OUP) in Molecular Human Reproduction
- Vol. 30 (9)
Open AccessMaturational competence of equine oocytes is associated with alterations in their ‘cumulome’
Assisted reproductive technologies are an emerging field in equine reproduction, with species dependent peculiarities, such as the low success rate of conventional in vitro fertilisation. Here, the “cumulome” was related to the developmental capacity of its corresponding oocyte. Cumulus oocyte complexes (COCs) collected from slaughterhouse ovaries were individually matured, fertilised by intracytoplasmic sperm injection (ICSI), and cultured. After maturation, the cumulus was collected for proteomics analysis using label-free mass spectrometry (MS) based protein profiling by nano-HPLC MS/MS and metabolomics analysis by UPLC-nanoESI MS. Overall, a total of 1671 proteins and 612 metabolites were included in the quantifiable “cumulome”. According to the development of the corresponding oocytes, three groups were compared with each other: not matured (NM; n = 18), cleaved (CV; n = 15) and blastocyst (BL; n = 19) groups. CV and BL were also analysed together as the matured group (M; n = 34). The dataset revealed a closer connection within the two M groups and a more distinct separation from the NM group. Over-representation analysis detected enrichments related to energy metabolism as well as vesicular transport in the M group. Functional enrichment analysis found only the KEGG pathway of oxidative phosphorylation as significantly enriched in NM group. A compound attributed to ATP was observed with significantly higher concentrations in the BL group compared with the NM group. Finally, in the NM group, proteins related to degradation of glycosaminoglycans were lower and components of cumulus extracellular matrix were higher compared to the other groups. In summary, the study revealed novel pathways associated with the maturational and developmental competence of oocytes.
- Open Access
- 18 June 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-15
The bovine cumulus proteome is influenced by maturation condition and maturational competence of the oocyte
In vitro maturation (IVM) of oocytes has still a negative impact on the developmental competence of oocytes. Therefore, this study analysed the cumulus proteome of individual cumulus-oocyte complexes (COCs) with and without maturational competence, matured under in vivo or in vitro conditions (n = 5 per group). A novel, ultrasensitive mass spectrometry (MS) based protein profiling approach, using label-free quantification, was applied. The detected cumulus proteome included 2226 quantifiable proteins and was highly influenced by the maturation condition (479 differentially expressed proteins) as well as maturational competence of the corresponding oocyte (424 differentially expressed proteins). Enrichment analysis showed an overrepresentation of the complement and coagulation cascades (CCC), ECM-receptor interaction and steroid biosynthesis in cumulus of COCs that matured successfully under in vivo conditions. Verification of the origin of CCC proteins was achieved through detection of C3 secretion into the maturation medium, with significantly increasing concentrations from 12 (48.4 ng/ml) to 24 hours (68 ng/ml: p < 0.001). In relation, concentrations in follicular fluid, reflecting the in vivo situation, were >100x higher. In summary, this study identified important pathways that are impaired in IVM cumulus, as well as potential markers of the maturational competence of oocytes.
- 18 June 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-15
Open AccessThe bovine cumulus proteome is influenced by maturation condition and maturational competence of the oocyte
In vitro maturation (IVM) of oocytes has still a negative impact on the developmental competence of oocytes. Therefore, this study analysed the cumulus proteome of individual cumulus-oocyte complexes (COCs) with and without maturational competence, matured under in vivo or in vitro conditions (n = 5 per group). A novel, ultrasensitive mass spectrometry (MS) based protein profiling approach, using label-free quantification, was applied. The detected cumulus proteome included 2226 quantifiable proteins and was highly influenced by the maturation condition (479 differentially expressed proteins) as well as maturational competence of the corresponding oocyte (424 differentially expressed proteins). Enrichment analysis showed an overrepresentation of the complement and coagulation cascades (CCC), ECM-receptor interaction and steroid biosynthesis in cumulus of COCs that matured successfully under in vivo conditions. Verification of the origin of CCC proteins was achieved through detection of C3 secretion into the maturation medium, with significantly increasing concentrations from 12 (48.4 ng/ml) to 24 hours (68 ng/ml: p < 0.001). In relation, concentrations in follicular fluid, reflecting the in vivo situation, were >100x higher. In summary, this study identified important pathways that are impaired in IVM cumulus, as well as potential markers of the maturational competence of oocytes.
- Open Access
- 17 July 2019
- Published by Springer Nature in BMC Genomics
- Vol. 20 (1) , 1-24
Analysis of the equine “cumulome” reveals major metabolic aberrations after maturation in vitro
Maturation of oocytes under in vitro conditions (IVM) results in impaired developmental competence compared to oocytes matured in vivo. As oocytes are closely coupled to their cumulus complex, elucidating aberrations in cumulus metabolism in vitro is important to bridge the gap towards more physiological maturation conditions. The aim of this study was to analyze the equine “cumulome” in a novel combination of proteomic (nano-HPLC MS/MS) and metabolomic (UPLC-nanoESI-MS) profiling of single cumulus complexes of metaphase II oocytes matured either in vivo (n = 8) or in vitro (n = 7). A total of 1811 quantifiable proteins and 906 metabolic compounds were identified. The proteome contained 216 differentially expressed proteins (p ≤ 0.05; FC ≥ 2; 95 decreased and 121 increased in vitro), and the metabolome contained 108 metabolites with significantly different abundance (p ≤ 0.05; FC ≥ 2; 24 decreased and 84 increased in vitro). The in vitro “cumulome” was summarized in the following 10 metabolic groups (containing 78 proteins and 21 metabolites): (1) oxygen supply, (2) glucose metabolism, (3) fatty acid metabolism, (4) oxidative phosphorylation, (5) amino acid metabolism, (6) purine and pyrimidine metabolism, (7) steroid metabolism, (8) extracellular matrix, (9) complement cascade and (10) coagulation cascade. The KEGG pathway “complement and coagulation cascades” (ID4610; n = 21) was significantly overrepresented after in vitro maturation. The findings indicate that the in vitro condition especially affects central metabolism and extracellular matrix composition. Important candidates for the metabolic group oxygen supply were underrepresented after maturation in vitro. Additionally, a shift towards glycolysis was detected in glucose metabolism. Therefore, under in vitro conditions, cumulus cells seem to preferentially consume excess available glucose to meet their energy requirements. Proteins involved in biosynthetic processes for fatty acids, cholesterol, amino acids, and purines exhibited higher abundances after maturation in vitro. This study revealed the marked impact of maturation conditions on the “cumulome” of individual cumulus oocyte complexes. Under the studied in vitro milieu, cumulus cells seem to compensate for a lack of important substrates by shifting to aerobic glycolysis. These findings will help to adapt culture media towards more physiological conditions for oocyte maturation.
- 17 July 2019
- Published by Springer Nature in BMC Genomics
- Vol. 20 (1) , 1-24
Open AccessAnalysis of the equine “cumulome” reveals major metabolic aberrations after maturation in vitro
Maturation of oocytes under in vitro conditions (IVM) results in impaired developmental competence compared to oocytes matured in vivo. As oocytes are closely coupled to their cumulus complex, elucidating aberrations in cumulus metabolism in vitro is important to bridge the gap towards more physiological maturation conditions. The aim of this study was to analyze the equine “cumulome” in a novel combination of proteomic (nano-HPLC MS/MS) and metabolomic (UPLC-nanoESI-MS) profiling of single cumulus complexes of metaphase II oocytes matured either in vivo (n = 8) or in vitro (n = 7). A total of 1811 quantifiable proteins and 906 metabolic compounds were identified. The proteome contained 216 differentially expressed proteins (p ≤ 0.05; FC ≥ 2; 95 decreased and 121 increased in vitro), and the metabolome contained 108 metabolites with significantly different abundance (p ≤ 0.05; FC ≥ 2; 24 decreased and 84 increased in vitro). The in vitro “cumulome” was summarized in the following 10 metabolic groups (containing 78 proteins and 21 metabolites): (1) oxygen supply, (2) glucose metabolism, (3) fatty acid metabolism, (4) oxidative phosphorylation, (5) amino acid metabolism, (6) purine and pyrimidine metabolism, (7) steroid metabolism, (8) extracellular matrix, (9) complement cascade and (10) coagulation cascade. The KEGG pathway “complement and coagulation cascades” (ID4610; n = 21) was significantly overrepresented after in vitro maturation. The findings indicate that the in vitro condition especially affects central metabolism and extracellular matrix composition. Important candidates for the metabolic group oxygen supply were underrepresented after maturation in vitro. Additionally, a shift towards glycolysis was detected in glucose metabolism. Therefore, under in vitro conditions, cumulus cells seem to preferentially consume excess available glucose to meet their energy requirements. Proteins involved in biosynthetic processes for fatty acids, cholesterol, amino acids, and purines exhibited higher abundances after maturation in vitro. This study revealed the marked impact of maturation conditions on the “cumulome” of individual cumulus oocyte complexes. Under the studied in vitro milieu, cumulus cells seem to compensate for a lack of important substrates by shifting to aerobic glycolysis. These findings will help to adapt culture media towards more physiological conditions for oocyte maturation.
- 1 June 2016
- Published by Elsevier in Journal of Equine Veterinary Science
- Vol. 41, 79
Maturation Condition alters the Cumulus Proteome of Equine Oocytes
- 1 June 2016
- Published by Elsevier in Journal of Equine Veterinary Science
- Vol. 41, 79
Maturation Condition alters the Cumulus Proteome of Equine Oocytes
- 1 June 2016
- Published by Elsevier in Journal of Equine Veterinary Science
- Vol. 41, 77-78
Developmental Competence of Equine Oocytes is Associated with Alterations in their Cumulus Proteome
- 1 June 2016
- Published by Elsevier in Journal of Equine Veterinary Science
- Vol. 41, 77-78
Developmental Competence of Equine Oocytes is Associated with Alterations in their Cumulus Proteome
- 1 January 2016
- Published by Georg Thieme Verlag KG in Tierärztliche Praxis Ausgabe G: Großtiere / Nutztiere
- Vol. 44 (05) , 313-317
Prävention der equinen Herpesvirus-Myeloenzephalopathie – Ist Heparin eine vielversprechende Option?
Die equine Herpesvirus-Myeloenzephalopathie (EHM) ist ein dramatischer Verlauf der Infektion mit equinem Herpesvirus 1 (EHV 1). Für die Prävention der EHM bei EHV-1-Ausbrüchen stehen bislang keine verlässlichen Medikamente zur Verfügung. Aufgrund der ursächlichen Thromboischämie im Bereich des Rückenmarks und der Fähigkeit von Heparin, den Viruseintritt in Zellen in vitro zu blockieren, entstand die Hypothese, dass die Verabreichung von Heparin an EHV-1-infizierte Pferde die Inzidenz der EHM reduzieren könnte. Daher wurde während eines akuten Ausbruchs mit der neuropathogenen Variante von EHV 1(G2254/D752 Pol) Heparin metaphylaktisch eingesetzt. Der Ausbruch betraf 61 Pferde. Alle Pferde, die ab Tag 10 des Ausbruchs Fieber zeigten (n = 31), wurden mit Heparin (25000 IU zweimal täglich subkutan über 3 Tage) behandelt, während die bis zu diesem Zeitpunkt erkrankten Pferde kein Heparin erhielten. Die mit Heparin therapierten Pferde entwickelten statistisch signifikant (p = 0,03) seltener Symptome der EHM (1/31; 3,2%) als die Pferde ohne Heparinapplikation (7/30; 23,3%). Die Ergebnisse dieser Fallstudie weisen darauf hin, dass die Verabreichung von Heparin an Pferde, die an einer EHV-1-Infektion erkrankt sind, das Risiko für EHM senken könnte. Hierzu sind randomisierte und gegebenenfalls geblindete Studien erforderlich. Equine herpesvirus myeloencephalopathy (EHM) is a severe manifestation of equine herpesvirus 1 (EHV-1) infection. Prevention and treatment of EHM during EHV-1 outbreaks is critical, but no reliable and tested specific medication is available. Due to the thromboischemic nature of EHM and due to the fact that EHV-1 entry in cells is blocked by heparin, it was hypothesized that this compound may be useful in reduction of EHM incidence and severity. Therefore, during an acute EHV-1 outbreak with the neuropathogenic G2254/D752 Pol variant, metaphylactic treatment with heparin to prevent EHM was initiated. Clinical signs were present in 61 horses (fever n = 55; EHM n = 8; abortion n = 6). Heparin (25000 IU subcutaneously twice daily for 3 days) was given to 31 febrile horses from day 10 of the outbreak, while the first 30 horses exhibiting fever remained untreated. Treatment outcome was analyzed retrospectively. Heparin-treated horses showed a lower EHM incidence (1/31; 3.2%) than untreated horses (7/30; 23.3%; p = 0.03). Results indicate that heparin may be useful for prevention of EHM during an EHV-1 outbreak. These promising data highlight the need for randomized and possibly blinded studies for the use of heparin in EHV-1 outbreaks.
- 1 January 2016
- Published by Georg Thieme Verlag KG in Tierärztliche Praxis Ausgabe G: Großtiere / Nutztiere
- Vol. 44 (05) , 313-317
Prävention der equinen Herpesvirus-Myeloenzephalopathie – Ist Heparin eine vielversprechende Option?
Die equine Herpesvirus-Myeloenzephalopathie (EHM) ist ein dramatischer Verlauf der Infektion mit equinem Herpesvirus 1 (EHV 1). Für die Prävention der EHM bei EHV-1-Ausbrüchen stehen bislang keine verlässlichen Medikamente zur Verfügung. Aufgrund der ursächlichen Thromboischämie im Bereich des Rückenmarks und der Fähigkeit von Heparin, den Viruseintritt in Zellen in vitro zu blockieren, entstand die Hypothese, dass die Verabreichung von Heparin an EHV-1-infizierte Pferde die Inzidenz der EHM reduzieren könnte. Daher wurde während eines akuten Ausbruchs mit der neuropathogenen Variante von EHV 1(G2254/D752 Pol) Heparin metaphylaktisch eingesetzt. Der Ausbruch betraf 61 Pferde. Alle Pferde, die ab Tag 10 des Ausbruchs Fieber zeigten (n = 31), wurden mit Heparin (25000 IU zweimal täglich subkutan über 3 Tage) behandelt, während die bis zu diesem Zeitpunkt erkrankten Pferde kein Heparin erhielten. Die mit Heparin therapierten Pferde entwickelten statistisch signifikant (p = 0,03) seltener Symptome der EHM (1/31; 3,2%) als die Pferde ohne Heparinapplikation (7/30; 23,3%). Die Ergebnisse dieser Fallstudie weisen darauf hin, dass die Verabreichung von Heparin an Pferde, die an einer EHV-1-Infektion erkrankt sind, das Risiko für EHM senken könnte. Hierzu sind randomisierte und gegebenenfalls geblindete Studien erforderlich. Equine herpesvirus myeloencephalopathy (EHM) is a severe manifestation of equine herpesvirus 1 (EHV-1) infection. Prevention and treatment of EHM during EHV-1 outbreaks is critical, but no reliable and tested specific medication is available. Due to the thromboischemic nature of EHM and due to the fact that EHV-1 entry in cells is blocked by heparin, it was hypothesized that this compound may be useful in reduction of EHM incidence and severity. Therefore, during an acute EHV-1 outbreak with the neuropathogenic G2254/D752 Pol variant, metaphylactic treatment with heparin to prevent EHM was initiated. Clinical signs were present in 61 horses (fever n = 55; EHM n = 8; abortion n = 6). Heparin (25000 IU subcutaneously twice daily for 3 days) was given to 31 febrile horses from day 10 of the outbreak, while the first 30 horses exhibiting fever remained untreated. Treatment outcome was analyzed retrospectively. Heparin-treated horses showed a lower EHM incidence (1/31; 3.2%) than untreated horses (7/30; 23.3%; p = 0.03). Results indicate that heparin may be useful for prevention of EHM during an EHV-1 outbreak. These promising data highlight the need for randomized and possibly blinded studies for the use of heparin in EHV-1 outbreaks.
- Open Access
- 31 January 2015
- Published by Springer Nature in BMC Veterinary Research
- Vol. 11 (1) , 1-8
Skin malformations in a neonatal foal tested homozygous positive for Warmblood Fragile Foal Syndrome
Skin malformations that resembled manifestations of Ehlers-Danlos-Syndrome were described in a variety of domestic animals during the last century as cutis hyperelastica, hyperelastosis cutis, dermatosparaxis, dermal/collagen dysplasia, dermal/cutaneous asthenia or Ehlers-Danlos-like syndrome/s. In 2007, the mutation responsible for Hereditary Equine Regional Dermal Asthenia (HERDA) in Quarter Horses was discovered. Several case reports are available for similar malformations in other breeds than Quarter Horses (Draught Horses, Arabians, and Thoroughbreds) including four case reports for Warmblood horses. Since 2013, a genetic test for the Warmblood Fragile Foal Syndrome Type 1 (WFFS), interrogating the causative point mutation in the equine procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1 (PLOD1, or lysyl hydroxylase 1) gene, has become available. Only limited data are available on the occurrence rate and clinical characteristics of this newly detected genetic disease in horses. In humans mutations in this gene are associated with Ehlers-Danlos Syndrome Type VI (kyphoscoliotic form). This is the first report describing the clinical and histopathological findings in a foal confirmed to be homozygous positive for WFFS. The Warmblood filly was born with very thin, friable skin, skin lesions on the legs and the head, and an open abdomen. These abnormalities required euthanasia just after delivery. Histologic examination revealed abnormally thin dermis, markedly reduced amounts of dermal collagen bundles, with loosely orientation and abnormally large spaces between deep dermal fibers. WFFS is a novel genetic disease in horses and should be considered in cases of abortion, stillbirth, skin lesions and malformations of the skin in neonatal foals. Genetic testing of suspicious cases will contribute to evaluate the frequency of occurrence of clinical WFFS cases and its relevance for the horse population.
- 31 January 2015
- Published by Springer Nature in BMC Veterinary Research
- Vol. 11 (1) , 1-8
Open AccessSkin malformations in a neonatal foal tested homozygous positive for Warmblood Fragile Foal Syndrome
Skin malformations that resembled manifestations of Ehlers-Danlos-Syndrome were described in a variety of domestic animals during the last century as cutis hyperelastica, hyperelastosis cutis, dermatosparaxis, dermal/collagen dysplasia, dermal/cutaneous asthenia or Ehlers-Danlos-like syndrome/s. In 2007, the mutation responsible for Hereditary Equine Regional Dermal Asthenia (HERDA) in Quarter Horses was discovered. Several case reports are available for similar malformations in other breeds than Quarter Horses (Draught Horses, Arabians, and Thoroughbreds) including four case reports for Warmblood horses. Since 2013, a genetic test for the Warmblood Fragile Foal Syndrome Type 1 (WFFS), interrogating the causative point mutation in the equine procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1 (PLOD1, or lysyl hydroxylase 1) gene, has become available. Only limited data are available on the occurrence rate and clinical characteristics of this newly detected genetic disease in horses. In humans mutations in this gene are associated with Ehlers-Danlos Syndrome Type VI (kyphoscoliotic form). This is the first report describing the clinical and histopathological findings in a foal confirmed to be homozygous positive for WFFS. The Warmblood filly was born with very thin, friable skin, skin lesions on the legs and the head, and an open abdomen. These abnormalities required euthanasia just after delivery. Histologic examination revealed abnormally thin dermis, markedly reduced amounts of dermal collagen bundles, with loosely orientation and abnormally large spaces between deep dermal fibers. WFFS is a novel genetic disease in horses and should be considered in cases of abortion, stillbirth, skin lesions and malformations of the skin in neonatal foals. Genetic testing of suspicious cases will contribute to evaluate the frequency of occurrence of clinical WFFS cases and its relevance for the horse population.
- Open Access
- 5 March 2013
- Published by Springer Nature in Acta Veterinaria Scandinavica
- Vol. 55 (1) , 19
Clinical observations and management of a severe equine herpesvirus type 1 outbreak with abortion and encephalomyelitis
Latent equine herpesvirus type 1 (EHV-1) infection is common in horse populations worldwide and estimated to reach a prevalence nearing 90% in some areas. The virus causes acute outbreaks of disease that are characterized by abortion and sporadic cases of myeloencephalopathy (EHM), both severe threats to equine facilities. Different strains vary in their abortigenic and neuropathogenic potential and the simultaneous occurrence of EHM and abortion is rare. In this report, we present clinical observations collected during an EHV-1 outbreak caused by a so-called “neuropathogenic” EHV-1 G2254/D752 polymerase (Pol) variant, which has become more prevalent in recent years and is less frequently associated with abortions. In this outbreak with 61 clinically affected horses, 6/7 pregnant mares aborted and 8 horses developed EHM. Three abortions occurred after development of EHM symptoms. Virus detection was performed by nested PCR targeting gB from nasal swabs (11 positive), blood serum (6 positive) and peripheral blood mononuclear cells (9 positive) of a total of 42 horses sampled. All 6 fetuses tested positive for EHV-1 by PCR and 4 by virus isolation. Paired serum neutralization test (SNT) on day 12 and 28 after the index case showed a significant (≥ 4-fold) increase in twelve horses (n = 42; 28.6%). This outbreak with abortions and EHM cases on a single equine facility provided a unique opportunity for the documentation of clinical disease progression as well as diagnostic procedures.
- 5 March 2013
- Published by Springer Nature in Acta Veterinaria Scandinavica
- Vol. 55 (1) , 19
Open AccessClinical observations and management of a severe equine herpesvirus type 1 outbreak with abortion and encephalomyelitis
Latent equine herpesvirus type 1 (EHV-1) infection is common in horse populations worldwide and estimated to reach a prevalence nearing 90% in some areas. The virus causes acute outbreaks of disease that are characterized by abortion and sporadic cases of myeloencephalopathy (EHM), both severe threats to equine facilities. Different strains vary in their abortigenic and neuropathogenic potential and the simultaneous occurrence of EHM and abortion is rare. In this report, we present clinical observations collected during an EHV-1 outbreak caused by a so-called “neuropathogenic” EHV-1 G2254/D752 polymerase (Pol) variant, which has become more prevalent in recent years and is less frequently associated with abortions. In this outbreak with 61 clinically affected horses, 6/7 pregnant mares aborted and 8 horses developed EHM. Three abortions occurred after development of EHM symptoms. Virus detection was performed by nested PCR targeting gB from nasal swabs (11 positive), blood serum (6 positive) and peripheral blood mononuclear cells (9 positive) of a total of 42 horses sampled. All 6 fetuses tested positive for EHV-1 by PCR and 4 by virus isolation. Paired serum neutralization test (SNT) on day 12 and 28 after the index case showed a significant (≥ 4-fold) increase in twelve horses (n = 42; 28.6%). This outbreak with abortions and EHM cases on a single equine facility provided a unique opportunity for the documentation of clinical disease progression as well as diagnostic procedures.
- Open Access
- 4 September 2012
- Published by Oxford University Press (OUP) in Journal of Veterinary Internal Medicine
- Vol. 26 (6) , 1500-1504
Venereal Shedding of Equid Herpesvirus-1 (EHV-1) in Naturally Infected Stallions
Background Equid herpesvirus 1 (EHV-1) is a highly prevalent pathogen in horse populations worldwide. Oronasal infection represents the classic route of disease transmission. Venereal shedding of EHV-1 is not regarded relevant in terms of virus spreading, which is in contrast to the close relatives of EHV-1, bovine and suid alphaherpesvirus, for which artificial insemination is a well-documented and accepted means of virus spread. Objectives Documentation of venereal EHV-1 shedding in 3 naturally infected stallions. Animals Three stallions were infected during an acute outbreak by an EHV-1 strain with the G2254/D752 Pol genotype. Methods In this observational study, 12 semen samples from these 3 stallions were tested for EHV-1 to determine venereal shedding. EHV-1 was diagnosed by conventional PCR and paired serum neutralization tests in 42 horses. Semen samples were separated into sperm and seminal plasma fractions and tested for EHV-1 by conventional and quantitative PCR as well as virus isolation by cell culture. Results Acute EHV-1 infection was diagnosed on the premise. Five semen samples collected from 2 of the 3 stallions tested positive for EHV-1 by (q)PCR. On days 18 and 20 after onset of fever, the last positive samples were retrieved. All samples were positive in seminal plasma, only three in sperm fraction. Virus isolation attempts were unsuccessful. Conclusions and Clinical Importance The data presented here document shedding of EHV-1 in semen of naturally infected stallions for close to 3 weeks, which seems not to be directly associated with spermatozoa.
- 4 September 2012
- Published by Oxford University Press (OUP) in Journal of Veterinary Internal Medicine
- Vol. 26 (6) , 1500-1504
Open AccessVenereal Shedding of Equid Herpesvirus-1 (EHV-1) in Naturally Infected Stallions
Background Equid herpesvirus 1 (EHV-1) is a highly prevalent pathogen in horse populations worldwide. Oronasal infection represents the classic route of disease transmission. Venereal shedding of EHV-1 is not regarded relevant in terms of virus spreading, which is in contrast to the close relatives of EHV-1, bovine and suid alphaherpesvirus, for which artificial insemination is a well-documented and accepted means of virus spread. Objectives Documentation of venereal EHV-1 shedding in 3 naturally infected stallions. Animals Three stallions were infected during an acute outbreak by an EHV-1 strain with the G2254/D752 Pol genotype. Methods In this observational study, 12 semen samples from these 3 stallions were tested for EHV-1 to determine venereal shedding. EHV-1 was diagnosed by conventional PCR and paired serum neutralization tests in 42 horses. Semen samples were separated into sperm and seminal plasma fractions and tested for EHV-1 by conventional and quantitative PCR as well as virus isolation by cell culture. Results Acute EHV-1 infection was diagnosed on the premise. Five semen samples collected from 2 of the 3 stallions tested positive for EHV-1 by (q)PCR. On days 18 and 20 after onset of fever, the last positive samples were retrieved. All samples were positive in seminal plasma, only three in sperm fraction. Virus isolation attempts were unsuccessful. Conclusions and Clinical Importance The data presented here document shedding of EHV-1 in semen of naturally infected stallions for close to 3 weeks, which seems not to be directly associated with spermatozoa.
- 1 June 2012
- Published by Elsevier in Animal Reproduction Science
- Vol. 132 (3-4) , 178-186
Cytological diagnosis of endometritis in the mare: Investigations of sampling techniques and relation to bacteriological results
- 1 June 2012
- Published by Elsevier in Animal Reproduction Science
- Vol. 132 (3-4) , 178-186
Cytological diagnosis of endometritis in the mare: Investigations of sampling techniques and relation to bacteriological results